About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

AtriCure is the latest player to throw its hat into pulsed-field ablation. The Mason, OH-based company revealed plans during an earnings call earlier this week. Michael Carrel, president and CEO, ...

Understanding the full range of technological options in intervention catheter composite design is essential to meet the increasingly demanding requirements of catheter-based devices and delivery ...

A camera-carrying pill may soon be available as a painless alternative to invasive gastrointestinal endoscopy. The disposable capsule, which will be marketed by Given Imaging Ltd. (Yokneam, Israel), ...

In December 2014, OtisMed Corporation agreed to pay more than $80 million after acknowledging that the company and its ex-CEO knowingly sold surgical cutting guides for knee replacements even though ...

Examining the evolving dynamics between EU and FDA regulations for medical devices. The webinar will address the historical practice of obtaining a CE Mark in Europe first, contrasting it with the ...

Graphic accompanying Pedersen's POV, a weekly op-ed column by MD+DI Senior Editor Amanda Pedersen, for the medtech industry.

Sign up for the QMED & MD+DI Daily newsletter.

Startups and emerging medtechs are the lifeblood of medical device innovation. And yet, not enough people are talking about how these innovators are facing unprecedented challenges that have already ...

The Omnigraft(TM) Dermal Regeneration Matrix from Integra LifeSciences is used to encourage the growth of skin tissue. According to the company, the product consists of a silicone layer used to shield ...

Duane Morris Silicon Valley office partner Agatha H. Liu, PhD, practices intellectual property law, focusing on IP analysis, portfolio management, and strategic counseling. Drawing on more than 20 ...

The global medical device packaging market is expected to be grow from an estimated $12,409.8 million to $20,914 million in 2033, surging at a stable compound annual growth rate (CAGR) of 6.1% over ...